APA (7th ed.) Citation

Wang, M. L., Jurczak, W., Zinzani, P. L., Eyre, T. A., Cheah, C. Y., Ujjani, C. S., . . . Shah, N. N. (2023). Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma. Journal of Clinical Oncology, 41(24), 3988-3997. https://doi.org/10.1200/jco.23.00562

Chicago Style (17th ed.) Citation

Wang, Michael L., et al. "Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma." Journal of Clinical Oncology 41, no. 24 (2023): 3988-3997. https://doi.org/10.1200/jco.23.00562.

MLA (9th ed.) Citation

Wang, Michael L., et al. "Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma." Journal of Clinical Oncology, vol. 41, no. 24, 2023, pp. 3988-3997, https://doi.org/10.1200/jco.23.00562.